FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel's review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)
A nurse prepares a shot of the vaccine developed by the National Institutes of Health and Moderna in December. AP

FDA panel approves use of Moderna vaccine in US




View from DC

The inside scoop from The National’s Washington bureau

      By signing up, I agree to The National's privacy policy
      View from DC